Annual long term liabilities:
$528.49M+$351.41M(+198.45%)Summary
- As of today (August 23, 2025), GMAB annual total long term liabilities is $528.49 million, with the most recent change of +$351.41 million (+198.45%) on December 31, 2024.
- During the last 3 years, GMAB annual long term liabilities has risen by +$396.54 million (+300.52%).
- GMAB annual long term liabilities is now at all-time high.
Performance
GMAB Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$401.01M-$4.00M(-0.99%)Summary
- As of today (August 23, 2025), GMAB quarterly total long term liabilities is $401.01 million, with the most recent change of -$4.00 million (-0.99%) on June 1, 2025.
- Over the past year, GMAB quarterly long term liabilities has increased by +$61.70 million (+18.18%).
- GMAB quarterly long term liabilities is now -0.99% below its all-time high of $405.01 million, reached on March 31, 2025.
Performance
GMAB quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
GMAB Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +198.4% | +18.2% |
| 3 y3 years | +300.5% | +171.7% |
| 5 y5 years | +2126.7% | +231.4% |
GMAB Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +300.5% | -1.0% | +192.4% |
| 5 y | 5-year | at high | +2126.7% | -1.0% | +231.4% |
| alltime | all time | at high | >+9999.0% | -1.0% | >+9999.0% |
GMAB Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $401.01M(-1.0%) |
| Mar 2025 | - | $405.01M(+1.7%) |
| Dec 2024 | $528.49M(+198.4%) | $398.38M(+17.9%) |
| Sep 2024 | - | $337.90M(-0.4%) |
| Jun 2024 | - | $339.31M(+64.6%) |
| Mar 2024 | - | $206.18M(+16.4%) |
| Dec 2023 | $177.08M(+21.7%) | $177.08M(+1.9%) |
| Sep 2023 | - | $173.78M(-3.6%) |
| Jun 2023 | - | $180.22M(-1.1%) |
| Mar 2023 | - | $182.16M(+25.2%) |
| Dec 2022 | $145.53M(+10.3%) | $145.53M(+6.1%) |
| Sep 2022 | - | $137.16M(-7.1%) |
| Jun 2022 | - | $147.61M(+15.3%) |
| Mar 2022 | - | $128.04M(-3.0%) |
| Dec 2021 | $131.95M(+4.4%) | $131.95M(-2.7%) |
| Sep 2021 | - | $135.60M(-3.4%) |
| Jun 2021 | - | $140.34M(+8.0%) |
| Mar 2021 | - | $129.90M(+2.8%) |
| Dec 2020 | $126.41M(+432.6%) | $126.41M(+2.0%) |
| Sep 2020 | - | $123.98M(+2.5%) |
| Jun 2020 | - | $121.01M(+398.8%) |
| Mar 2020 | - | $24.26M(+2.2%) |
| Dec 2019 | $23.73M(+4609.2%) | $23.73M(+1.0%) |
| Sep 2019 | - | $23.49M(-7.4%) |
| Jun 2019 | - | $25.37M(-1.9%) |
| Mar 2019 | - | $25.85M(+5028.5%) |
| Dec 2018 | $504.00K(-13.9%) | $504.00K(-5.7%) |
| Sep 2018 | - | $534.60K(-4.5%) |
| Jun 2018 | - | $560.00K(-8.7%) |
| Mar 2018 | - | $613.30K(+4.8%) |
| Dec 2017 | $585.30K(>+9900.0%) | $585.30K(+137.8%) |
| Sep 2017 | - | $246.10K(>+9900.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(-100.0%) |
| Jun 2016 | - | $214.00K(-2.4%) |
| Mar 2016 | - | $219.20K(+5.1%) |
| Dec 2015 | $208.60K(-99.3%) | $208.60K(-2.7%) |
| Sep 2015 | - | $214.40K(+0.2%) |
| Jun 2015 | - | $214.00K(-0.2%) |
| Mar 2015 | - | $214.50K(-99.3%) |
| Dec 2014 | $28.89M(-4.9%) | $28.89M(-4.3%) |
| Sep 2014 | - | $30.20M(-4.4%) |
| Jun 2014 | - | $31.58M(+3.2%) |
| Mar 2014 | - | $30.61M(+0.7%) |
| Dec 2013 | $30.38M(+36.4%) | $30.38M(+36.3%) |
| Sep 2013 | - | $22.30M(+3.8%) |
| Jun 2013 | - | $21.49M(+1.3%) |
| Mar 2013 | - | $21.21M(-4.8%) |
| Dec 2012 | $22.27M | $22.27M(+67.9%) |
| Sep 2012 | - | $13.27M(+3.3%) |
| Jun 2012 | - | $12.84M(-25.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $17.34M(-2.0%) |
| Dec 2011 | $17.69M(+27.8%) | $17.69M(+53.2%) |
| Sep 2011 | - | $11.54M(-8.9%) |
| Jun 2011 | - | $12.67M(-4.1%) |
| Mar 2011 | - | $13.22M(+12.9%) |
| Dec 2010 | $13.85M(+139.4%) | $11.72M(+70.8%) |
| Sep 2010 | - | $6.86M(-2.0%) |
| Jun 2010 | - | $7.00M(+46.1%) |
| Mar 2010 | - | $4.79M(-4.2%) |
| Dec 2009 | $5.79M(+126.6%) | $5.00M(-95.0%) |
| Sep 2009 | - | $99.75M(-6.1%) |
| Jun 2009 | - | $106.23M(-3.9%) |
| Mar 2009 | - | $110.52M(+6502.0%) |
| Dec 2008 | $2.55M(+59.1%) | - |
| Dec 2008 | - | $1.67M(-12.5%) |
| Sep 2008 | - | $1.91M(-20.5%) |
| Jun 2008 | - | $2.41M(-12.0%) |
| Mar 2008 | - | $2.74M(+70.6%) |
| Dec 2007 | $1.60M(-19.4%) | - |
| Dec 2007 | - | $1.60M(-15.0%) |
| Sep 2007 | - | $1.89M(-10.3%) |
| Jun 2007 | - | $2.10M(+20.9%) |
| Mar 2007 | - | $1.74M(-12.6%) |
| Dec 2006 | $1.99M(-85.3%) | - |
| Dec 2006 | - | $1.99M(-9.9%) |
| Sep 2006 | - | $2.21M(-12.7%) |
| Jun 2006 | - | $2.53M(-10.2%) |
| Mar 2006 | - | $2.81M(-79.2%) |
| Dec 2005 | $13.55M(+253.7%) | - |
| Dec 2005 | - | $13.55M(+408.5%) |
| Sep 2005 | - | $2.66M(-12.1%) |
| Jun 2005 | - | $3.03M(-2.8%) |
| Mar 2005 | - | $3.12M(-18.5%) |
| Dec 2004 | $3.83M(+21.8%) | - |
| Dec 2004 | - | $3.83M(+9.4%) |
| Sep 2004 | - | $3.50M(+11.2%) |
| Jun 2004 | - | $3.15M(+23.4%) |
| Mar 2004 | - | $2.55M(-19.0%) |
| Dec 2003 | $3.15M(-5.5%) | - |
| Dec 2003 | - | $3.15M(+49.6%) |
| Sep 2003 | - | $2.10M(-49.4%) |
| Jun 2003 | - | $4.16M(+23.8%) |
| Mar 2003 | - | $3.36M(+85.8%) |
| Dec 2002 | $3.33M(-6.9%) | - |
| Sep 2002 | - | $1.81M(-50.1%) |
| Jun 2002 | - | $3.62M(+2.0%) |
| Mar 2002 | - | $3.54M(-1.0%) |
| Dec 2001 | $3.58M(-30.3%) | $3.58M(+9.2%) |
| Sep 2001 | - | $3.28M(-35.5%) |
| Jun 2001 | - | $5.08M(-0.3%) |
| Mar 2001 | - | $5.10M |
| Dec 2000 | $5.13M(>+9900.0%) | - |
| Dec 1999 | $0.00 | - |
FAQ
- What is Genmab A/S annual total long term liabilities?
- What is the all time high annual long term liabilities for Genmab A/S?
- What is Genmab A/S annual long term liabilities year-on-year change?
- What is Genmab A/S quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Genmab A/S?
- What is Genmab A/S quarterly long term liabilities year-on-year change?
What is Genmab A/S annual total long term liabilities?
The current annual long term liabilities of GMAB is $528.49M
What is the all time high annual long term liabilities for Genmab A/S?
Genmab A/S all-time high annual total long term liabilities is $528.49M
What is Genmab A/S annual long term liabilities year-on-year change?
Over the past year, GMAB annual total long term liabilities has changed by +$351.41M (+198.45%)
What is Genmab A/S quarterly total long term liabilities?
The current quarterly long term liabilities of GMAB is $401.01M
What is the all time high quarterly long term liabilities for Genmab A/S?
Genmab A/S all-time high quarterly total long term liabilities is $405.01M
What is Genmab A/S quarterly long term liabilities year-on-year change?
Over the past year, GMAB quarterly total long term liabilities has changed by +$61.70M (+18.18%)